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LETTER TO THE EDITOR
Reply to Benito-Sanz et al.
To the Editor: We applaud the thorough characterization
by Benito-Sanz et al. (in this issue)1 of deletions encom-
passing the SHOX gene (MIM 312865) in patients with
Le´ri-Weill dyschondrosteosis (MIM 127300). Benito-Sanz
et al. suggest a founder effect to explain the apparent re-
combination hotspot we observed among our probands
with SHOX deletions.2 Indeed, four of our five probands
who shared both 5′ and 3′ breakpoints were Hispanic.
However, the same 3′ breakpoint was present in four non-
Hispanic white probands, only one of whom had the com-
mon 5′ breakpoint. Additional studies will be required to
determine whether the common SHOX deletion we ob-
served was recurrent or arose only once. Benito-Sanz et
al.1 also propose that diagnosis of SHOX disorders should
include testing for deletion of downstream Xp-Yp pseudo-
autosomal region 1 (PAR1) markers. It will be important
to determine whether any of the SNP or microsatellite
markers used in their study show deletion polymorphisms
among unaffected individuals, since such variations could
cause false-positive results in clinical testing. We agree with
the statement by Benito-Sanz et al. that Xp deletions ex-
tending beyond PAR1 have important genetic counseling
implications. Of the 49 deletions they mapped, 5 or 6 were
large enough to be visible cytogenetically; our results were
similar, but we excluded such deletions from our study.
We suggest a low threshold for karyotyping patients with
SHOX deletions, which may result not only from simple
deletions but also from complex chromosomal rearrange-
ments, such as unbalanced translocations or isodicentric
chromosomes.3,4
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